Cuprina Holdings (Cayman) Limited - Ordinary shares (CUPR)
Healthcare › Orthopedic, Prosthetic & Surgical Appliances & Supplies
Price History
Feb 9, 2026 — May 5, 2026Investment Snapshot
- P/B of 0.49 — trading below book value
- Piotroski F-Score 5/9 — moderate financial health
- Loss-making — negative ROE of -92.4%
- Revenue growing at 9% annually
Cuprina Holdings (Cayman) Limited - Ordinary shares (CUPR) is a Healthcare company operating in Orthopedic, Prosthetic & Surgical Appliances & Supplies, listed on the NASDAQ , with a market capitalisation of $2 million . Key value metrics: P/B ratio 0.49, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Cuprina Holdings (Cayman) Limited - Ordinary shares — Fundamental Analysis Summary
On financial health, CUPR shows a moderate Piotroski F-Score of 5/9, and negative return on equity of -92.4% (sector average: -20.6%), and minimal leverage with a debt-to-equity ratio of 0.03.
StockPik's composite Value Score for CUPR is 62/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
CUPR reports a thin gross margin of -1.3% (sector average: 40.1%) and a negative operating margin of -9,680.1%.
CUPR shows revenue growing at 9% year-over-year, with earnings declining at 217%.